X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15325) 15325
Book Review (2273) 2273
Publication (1797) 1797
Newsletter (211) 211
Government Document (156) 156
Book Chapter (128) 128
Conference Proceeding (68) 68
Dissertation (40) 40
Magazine Article (40) 40
Newspaper Article (35) 35
Book / eBook (10) 10
Trade Publication Article (8) 8
Web Resource (6) 6
Reference (4) 4
Data Set (3) 3
Journal / eJournal (1) 1
Presentation (1) 1
Streaming Video (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (11961) 11961
humans (11644) 11644
female (9482) 9482
breast cancer (6650) 6650
oncology (6580) 6580
brca1 (6239) 6239
breast neoplasms - genetics (6236) 6236
mutation (5685) 5685
genes, brca1 (4503) 4503
middle aged (4414) 4414
adult (4331) 4331
cancer (4253) 4253
genetic aspects (3644) 3644
brca1 protein - genetics (3403) 3403
ovarian neoplasms - genetics (3198) 3198
ovarian cancer (3094) 3094
genes, brca2 (3008) 3008
ovarian-cancer (2923) 2923
genetic predisposition to disease (2873) 2873
risk factors (2853) 2853
aged (2730) 2730
women (2602) 2602
genetics & heredity (2523) 2523
research (2473) 2473
risk (2299) 2299
brca2 (2106) 2106
breast-cancer (2071) 2071
mutations (1876) 1876
genes (1873) 1873
brca2 protein - genetics (1837) 1837
male (1785) 1785
health aspects (1783) 1783
brca1 protein (1767) 1767
genetic testing (1705) 1705
breast neoplasms - pathology (1458) 1458
genetics (1451) 1451
gene mutations (1442) 1442
animals (1438) 1438
dna repair (1420) 1420
biochemistry & molecular biology (1372) 1372
skin and connective tissue diseases (1332) 1332
brca2 protein (1317) 1317
germ-line mutation (1313) 1313
tumors (1312) 1312
cell biology (1293) 1293
breast (1290) 1290
brca mutations (1276) 1276
brca1 protein - metabolism (1231) 1231
analysis (1230) 1230
article (1187) 1187
dna damage (1155) 1155
brca (1095) 1095
heterozygote (1094) 1094
gene (1090) 1090
prognosis (1076) 1076
care and treatment (1032) 1032
breast neoplasms - epidemiology (1029) 1029
medicine & public health (1018) 1018
susceptibility (1009) 1009
diagnosis (974) 974
obstetrics & gynecology (974) 974
dna (967) 967
breast neoplasms - diagnosis (959) 959
carriers (949) 949
expression (943) 943
germline mutations (935) 935
aged, 80 and over (933) 933
genetic counseling (933) 933
proteins (932) 932
pedigree (903) 903
families (895) 895
homologous recombination (892) 892
risk assessment (891) 891
endocrine system diseases (887) 887
mice (876) 876
chemotherapy (865) 865
gene expression (861) 861
genetic screening (838) 838
surgery (837) 837
deoxyribonucleic acid--dna (824) 824
carcinoma (820) 820
survival (819) 819
cell line, tumor (815) 815
genetic research (802) 802
oncology, experimental (796) 796
neoplasm proteins - genetics (794) 794
dna mutational analysis (792) 792
breast neoplasms - prevention & control (789) 789
breast neoplasms - metabolism (767) 767
abridged index medicus (736) 736
ovarian neoplasms - pathology (731) 731
prevalence (716) 716
transcription factors - genetics (715) 715
repair (698) 698
case-control studies (678) 678
population (668) 668
epidemiology (665) 665
mutation - genetics (659) 659
pathology (657) 657
mutation carriers (656) 656
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15471) 15471
French (165) 165
German (73) 73
Russian (65) 65
Polish (40) 40
Spanish (40) 40
Czech (23) 23
Dutch (11) 11
Hungarian (11) 11
Korean (9) 9
Hebrew (6) 6
Bulgarian (5) 5
Croatian (5) 5
Italian (5) 5
Persian (5) 5
Danish (4) 4
Japanese (4) 4
Norwegian (4) 4
Portuguese (4) 4
Swedish (4) 4
Latvian (2) 2
Romanian (2) 2
Finnish (1) 1
Icelandic (1) 1
Serbian (1) 1
Slovenian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 07/2012, Volume 30, Issue 21, pp. 2654 - 2663
Purpose The frequency of BRCA1 and BRCA2 germ-line mutations in women with ovarian cancer is unclear; reports vary from 3% to 27%. The impact of germ-line... 
POLY(ADP-RIBOSE) POLYMERASE | CLEAR-CELL | ONCOLOGY | RESISTANCE | IMPROVED SURVIVAL | HOMOLOGOUS RECOMBINATION | CARCINOMA | CARRIERS | TUMORS | CHEMOTHERAPY | FEATURES | Medical History Taking | Recurrence | Prospective Studies | Humans | Middle Aged | Ovarian Neoplasms - pathology | Drug Resistance, Neoplasm | Cystadenocarcinoma, Serous - genetics | Cystadenocarcinoma, Serous - drug therapy | Case-Control Studies | Ovarian Neoplasms - genetics | Peritoneal Neoplasms - drug therapy | Neoplasm Grading | Fallopian Tube Neoplasms - genetics | Aged, 80 and over | Genes, BRCA2 | Germ-Line Mutation | Adult | Female | Genes, BRCA1 | Ovarian Neoplasms - drug therapy | Fallopian Tube Neoplasms - drug therapy | Carcinoma - drug therapy | Carcinoma, Endometrioid - genetics | Kaplan-Meier Estimate | Mutation Rate | Treatment Outcome | Carcinoma, Endometrioid - drug therapy | Australia - epidemiology | Ovarian Neoplasms - epidemiology | Disease-Free Survival | Point Mutation | Breast Neoplasms - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Peritoneal Neoplasms - genetics | Carcinoma - genetics | Aged | Platinum Compounds - administration & dosage | Neoplasm Staging | Adenocarcinoma, Clear Cell - genetics | Adenocarcinoma, Clear Cell - drug therapy | Cohort Studies | Index Medicus | Original Reports | Gynecologic Cancer | Gync21 | Gync15
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2015, Volume 137, Issue 3, pp. 386 - 391
Abstract Background Veliparib is a potent small molecule inhibitor of PARP-1/2, which is cytotoxic in tumor cells with deficiencies in BRCA1 or BRCA2 . We... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | BRCA1, BRCA2 mutation | Toxicity | Veliparib | PARP inhibitor | Phase II trial | Ovarian cancer | SENSITIVITY | OPEN-LABEL | COMBINATION | PLATINUM-FREE INTERVAL | SOMATIC MUTATIONS | OBSTETRICS & GYNECOLOGY | OLAPARIB | ONCOLOGY | RESISTANCE | HOMOLOGOUS RECOMBINATION | REFRACTORY SOLID TUMORS | POLY(ADP-RIBOSE) POLYMERASE INHIBITOR | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Ovarian Neoplasms - genetics | BRCA1 Protein - genetics | Neoplasms, Glandular and Epithelial - genetics | Peritoneal Neoplasms - drug therapy | Peritoneal Neoplasms - genetics | Fallopian Tube Neoplasms - genetics | Neoplasms, Glandular and Epithelial - drug therapy | Aged, 80 and over | Carcinoma, Ovarian Epithelial | Genes, BRCA2 | Germ-Line Mutation | Adult | Female | Neoplasm Recurrence, Local - genetics | Aged | Genes, BRCA1 | Benzimidazoles - adverse effects | Ovarian Neoplasms - drug therapy | BRCA2 Protein - genetics | Benzimidazoles - therapeutic use | Fallopian Tube Neoplasms - drug therapy | Medical research | Cancer patients | Care and treatment | Gene mutations | Analysis | Medicine, Experimental | Genetic aspects | Cancer | Chemotherapy | Clinical trials | Index Medicus | toxicity | BRCA2 mutation | ovarian cancer | veliparib | BRCA1
Journal Article
Journal Article
Journal Article
Journal Article
by Antoniou, Antonis C and Sinilnikova, Olga M and Simard, Jacques and Léoné, Mélanie and Dumont, Martine and Neuhausen, Susan L and Struewing, Jeffery P and Stoppa-Lyonnet, Dominique and Barjhoux, Laure and Hughes, David J and Coupier, Isabelle and Belotti, Muriel and Lasset, Christine and Bonadona, Valérie and Bignon, Yves-Jean and Rebbeck, Timothy R and Wagner, Theresa and Lynch, Henry T and Domchek, Susan M and Nathanson, Katherine L and Garber, Judy E and Weitzel, Jeffrey and Narod, Steven A and Tomlinson, Gail and Olopade, Olufunmilayo I and Godwin, Andrew and Isaacs, Claudine and Jakubowska, Anna and Lubinski, Jan and Gronwald, Jacek and Górski, Bohdan and Byrski, Tomasz and Huzarski, Tomasz and Peock, Susan and Cook, Margaret and Baynes, Caroline and Murray, Alexandra and Rogers, Mark and Daly, Peter A and Dorkins, Huw and Schmutzler, Rita K and Versmold, Beatrix and Engel, Christoph and Meindl, Alfons and Arnold, Norbert and Niederacher, Dieter and Deissler, Helmut and Spurdle, Amanda B and Chen, Xiaoqing and Waddell, Nicola and Cloonan, Nicole and Kirchhoff, Tomas and Offit, Kenneth and Friedman, Eitan and Kaufmann, Bella and Laitman, Yael and Galore, Gilli and Rennert, Gad and Lejbkowicz, Flavio and Raskin, Leon and Andrulis, Irene L and Ilyushik, Eduard and Ozcelik, Hilmi and Devilee, Peter and Vreeswijk, Maaike P.G and Greene, Mark H and Prindiville, Sheila A and Osorio, Ana and Benítez, Javier and Zikan, Michal and Szabo, Csilla I and Kilpivaara, Outi and Nevanlinna, Heli and Hamann, Ute and Durocher, Francine and Arason, Adalgeir and Couch, Fergus J and Easton, Douglas F and Chenevix-Trench, Georgia and Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab) and German Consortium for Hereditary Breast and Ovarian Cancer (GCHBOC) and Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers Study (GEMO) and Epidemiological Study of BRCA1 and BRCA2 Mutation Carriers (EMBRACE) and Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
The American Journal of Human Genetics, ISSN 0002-9297, 2007, Volume 81, Issue 6, pp. 1186 - 1200
Journal Article
JAMA - Journal of the American Medical Association, ISSN 0098-7484, 01/2019, Volume 321, Issue 1, pp. 27 - 28
The BRCA1 and BRCA2 act as biological markers for early detection of breast and ovarian cancer in women. The risks and benefits of mastectomy before... 
BREAST-CANCER | MEDICINE, GENERAL & INTERNAL | Care and treatment | Usage | Gene mutations | Mastectomy | Breast cancer | Genetic aspects | Research | Biological markers | Risk factors | Genetic screening | Ovarian cancer | Carriers | BRCA2 protein | Chemotherapy | BRCA1 protein | Health risks | Risk reduction | Risk | Mutation | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
by Pujade-Lauraine, Eric and Ledermann, Jonathan and Ledermann, Jonathan A and Selle, Frédéric and Gebski, Val and Penson, Richard and Penson, Richard T and Oza, Amit M and Oza, Amit and Korach, Jacob and Huzarski, Tomasz and Poveda, Andrés and Pignata, Sandro and Friedlander, Michael and Colombo, Nicoletta and Harter, Philipp and Fujiwara, Keiichi and Ray-Coquard, Isabelle and Banerjee, Susana and Liu, Joyce and Lowe, Elizabeth S and Bloomfield, Ralph and Pautier, Patricia and Byrski, Tomasz and Scambia, Giovanni and Nicoletto, Maria and Nussey, Fiona and Clamp, Andrew and Poveda Velasco, Andrés and Rodrigues, Manuel and Lotz, Jean-Pierre and Provencher, Diane and Prat Aparicio, Aleix and Vidal Boixader, Laura and Scott, Clare and Tamura, Kenji and Yunokawa, Mayu and Lisyanskaya, Alla and Medioni, Jacques and Pécuchet, Nicolas and Dubot, Coraline and de la Motte Rouge, Thibault and Kaminsky, Marie-Christine and Weber, Béatrice and Lortholary, Alain and Parkinson, Christine and Williams, Sarah and Cosin, Jonathan and Hoffman, James and Plante, Marie and Covens, Allan and Sonke, Gabe and Joly, Florence and Floquet, Anne and Hirte, Holger and Amit, Amnon and Park-Simon, Tjoung-Won and Matsumoto, Koji and Tjulandin, Sergei and Kim, Jae Hoon and Kim, Byoung-Gie and Kim, Jae Weon and Gladieff, Laurence and Sabbatini, Roberto and O'Malley, David and Timmins, Patrick and Kredentser, Daniel and Laínez Milagro, Nuria and Barretina Ginesta, Maria Pilar and Tibau Martorell, Ariadna and Gómez de Liaño Lista, Alfonso and Ojeda González, Belén and Mileshkin, Linda and Mandai, Masaki and Boere, Ingrid and Ottevanger, Petronella and Nam, Joo-Hyun and Filho, Elias and Hamizi, Salima and Cognetti, Francesco and Warshal, David and Dickson-Michelson, Elizabeth and Kamelle, Scott and McKenzie, Nathalie and Rodriguez, Gustavo and Armstrong, Deborah and Chalas, Eva and Celano, Paul and Behbakht, Kian and Davidson, Susan and Welch, Stephen and Helpman, Limor and Fishman, Ami and Bruchim, Ilan and Sikorska, Magdalena and Słowińska, Anna and Rogowski, Wojciech and Bidziński, Mariusz and Śpiewankiewicz, Beata and Casado Herraez, Antonio and ... and SOLO2-ENGOT-Ov21 Investigators and SOLO2/ENGOT-Ov21 investigators
The Lancet Oncology, ISSN 1470-2045, 09/2017, Volume 18, Issue 9, pp. 1274 - 1284
Journal Article
JAMA, ISSN 0098-7484, 02/2017, Volume 317, Issue 8, pp. 809 - 809
The article discusses the personal experiences of the author, a physician, with regards to ways to eradicate a genetic mutation. Some of the challenges... 
MEDICINE, GENERAL & INTERNAL | Pregnancy | Breast Neoplasms - genetics | Fertilization in Vitro | Humans | Preimplantation Diagnosis | Adult | Female | Genes, BRCA1 | Mutation | Breast Neoplasms - prevention & control | Gene mutations | Personal narratives | Authors | Reproductive technologies | Genes | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 6, pp. 523 - 533
Journal Article